Pressmeddelanden från Simris Alg

Bevaka pressreleaser

Kurs från TradingView

Start Nyheter Pressreleaser Riktkurser Insynshandel Blankning Analyser Bloggar Videos Podcasts

Simis provides an update on the divestment of its assets in Hammenhög, Sweden 28 feb 08:00

SIMRIS GROUP YEAR-END REPORT JANUARY-DECEMBER 2025 19 jan 16:30

Bulletin from Simris Group AB’s extraordinary general meeting 19 jan 14:00

Simris Group enters into Memorandum of Understanding regarding divestment of assets in Hammenhög 16 dec 2025 21:32

Simris Group AB (publ) receives notice of conversion of convertible bonds 16 dec 2025 20:45

Notice of extraordinary general meeting in Simris Group AB (publ)16 dec 2025 20:43

Simris Group AB resolves on directed issue of units, proposes that an extraordinary general meeting resolves on additional share issues and announces acceptance of premature conversion of convertible debentures 28 nov 2025 16:51

Simris Group enters into bridge loan agreement 12 nov 2025 08:00

SIMRIS GROUP INTERIM REPORT JANUARY-SEPTEMBER 2025 10 nov 2025 08:30

Simris Group announces leadership transition - Daniel Kubitza appointed interim CEO 05 nov 2025 13:00

Simris Group AB Announces Positive Results from Ongoing Antibody-Drug Conjugate (ADC) Study with Nuvisan 06 okt 2025 09:30

Update Regarding In-Vitro Evaluation of Novel Advance Microcystin Payloads 12 sep 2025 10:00

Simris Biologics awarded €200K in non-dilutive funding for R&D programme to further develop microcystin payloads for Antibody Drug Conjugates (ADCs)13 aug 2025 08:00

SIMRIS GROUP INTERIM REPORT JANUARY-JUNE 2025 27 jul 2025 21:57

Simris Group AB (publ) resolves on a directed issue of convertible debentures of EUR 678,000 and amends existing loan facilities 12 jul 2025 06:38

Partner Company Decides Not to Proceed with Simris Group ADC Proposed Collaboration Following Strategic Review 05 jun 2025 09:15

Simris Biologics Signs Agreement with Nuvisan for In-Vivo Evaluation of Novel Microcystin Payloads 02 jun 2025 08:55

Simris Group AB Signs Non-Binding Concept Sheet for Potential Antibody-Drug Conjugate Collaboration 28 maj 2025 17:10

Bulletin from Simris Group AB’s annual general meeting 14 maj 2025 08:00

SIMRIS GROUP INTERIM REPORT JANUARY-MARCH 2025 25 apr 2025 15:00

Notice of the Annual General Meeting of Simris Group AB (publ)16 apr 2025 18:05

Simris Group enters into bridge loan agreement, extends loan agreements with investors and intends to propose that the annual general meeting resolves to extend loan agreements with management 16 apr 2025 15:00

SIMRIS GROUP PUBLISHES ITS ANNUAL REPORT FOR 2024 25 mar 2025 08:00

Refined Microcystin Payloads Show Promising In-Vitro Efficacy, Paving Way for Next-Generation Variants 26 feb 2025 08:00

SIMRIS GROUP YEAR-END REPORT JANUARY-DECEMBER 2024 20 jan 2025 14:18

Bulletin from Simris Group AB’s Extraordinary General Meeting 23 dec 2024 11:07

Notice of Extraordinary General Meeting of Simris Group AB (publ)23 dec 2024 09:44

Simris resolves on a share issue, repayment of convertible debentures, prolongation of loan agreements, entering into and to call for a general meeting to resolve to enter into new loan agreements 13 nov 2024 08:00

SIMRIS GROUP INTERIM REPORT JANUARY-SEPTEMBER 2024 23 okt 2024 18:04

Uncertainty regarding when the next payment from the agreed loan facility can occur 18 okt 2024 18:22

Simris Group chairman and major owner Steven Schapera has passed away after complications after surgery 09 sep 2024 08:00

Simris Biologics awarded funding for a research collaboration with Berlin's University of Applied Science to explore the ability of natural compounds from Cyanobacteria to delay aging 14 aug 2024 08:00

SIMRIS GROUP INTERIM REPORT JANUARY-JUNE 2024 09 jul 2024 15:45

Simris Biologics enters into a collaboration agreement with New Zealand Universities to develop peptide drug conjugates (PDC)28 jun 2024 11:15

Bulletin from Simris Group AB (publ)’s Annual General Meeting 27 maj 2024 18:35

Notice of the Annual General Meeting of Simris Group AB (publ)15 maj 2024 08:00

SIMRIS GROUP INTERIM REPORT JANUARY-MARCH 2024 29 apr 2024 14:00

SIMRIS GROUP AB ANNOUNCED TODAY THAT THE BOARD HAS DECIDED TO MOVE THE COMPANY'S ANNUAL GENERAL MEETING FROM MAY 29, 2024 TO JUNE 28, 2024 23 apr 2024 14:10

Simris Group AB (publ) announces the outcome of the directed offer of convertible debentures 17 apr 2024 14:45

SIMRIS GROUP PUBLISHES ITS ANNUAL REPORT FOR 2023 15 apr 2024 20:30

SIMRIS GROUP CONFIRMS A TERM EXTENSION TO FLEXIBLE FUNDING FACILITY 05 apr 2024 11:15

Bulletin from Simris Group’s Extraordinary General Meeting 19 mar 2024 19:33

Notice of Extraordinary General Meeting of Simris Group AB (publ)15 mar 2024 21:34

The board of Simris Group AB (publ) resolves to change the terms of the directed issue of convertible debentures by increasing from EUR 1.0m to EUR €1.15m subject to the approval of the general meeting.14 mar 2024 18:35

The board of Simris Group AB (publ) resolves on a directed issue of convertible debentures up to EUR 1,000,000 subject to the approval of the General Meeting.12 mar 2024 21:10

Julian Read steps down as CEO of Simris Group. The Board of Simris appoints Dr Alexis Roberts-McIntosh as his successor with immediate effect.06 mar 2024 09:02

Simris Group AB confirms that it will temporarily pause production at its facility in Hammenhög, Sweden 28 feb 2024 08:00

SIMRIS GROUP YEAR-END REPORT JANUARY-DECEMBER 2023 10 jan 2024 08:00

Simris signs Head of Terms for an offtake agreement valued at minimum €2m / SEK 22m 20 dec 2023 10:45

Bulletin from Simris Group’s Extraordinary General Meeting 20 dec 2023 09:45

Simris Biologics signs Material Transfer Agreement with pre-clinical biotech company to develop Linker-Payloads 01 dec 2023 16:01

Notice of Extraordinary General Meeting of Simris Group AB (publ)01 dec 2023 16:00

The board of Simris Group AB (publ) proposes a directed share issue of approximately MSEK 1.55 15 nov 2023 14:15

Simris Biologics awarded €163,000 for the genetic engineering of cyanobacterial strains during an 18-month project beginning January 2024 08 nov 2023 08:00

Simris Group: Interim Report January - September 2023 07 nov 2023 15:30

Simris appoints a distribution partner for Omega-3 products in North America delivering revenue of approx., €60k, and annual cost savings of €200k 29 okt 2023 19:55

Simris Group AB completes a directed share issue of approximately 3 MSEK to strategic investors 11 sep 2023 14:40

Last day of trading with BTA in Simris Group 18 aug 2023 19:32

Simris Group AB (Publ) announces the final outcome of the fully secured Rights Issue 16 aug 2023 18:15

Preliminary subscription rate of Rights Issue in Simris Group AB (Publ) amounts to approximately 57 percent 11 aug 2023 08:25

BioStock: Emission ska ta Simris Group till första licensavtalet 08 aug 2023 14:15

Simris Group CEO, Julian Read, svarar på frågor från Finwire angående företagets strategi och den pågående företrädesemissionen 04 aug 2023 14:55

SIMRIS GROUP SIGNS LETTER OF INTENT TO SECURE INDUSTRIAL SCALE PRODUCTION CAPACITY THROUGH COMMERCIAL PARTNERSHIP 02 aug 2023 16:00

Simris Biologics confirms new patent application from its ADC-payload platform 31 jul 2023 19:15

Simris Group AB publishes information memorandum for the Rights Issue 31 jul 2023 16:55

Simris Group presents a forward-looking statement and a financial forecast for its subsidiary Simris Biologics 28 jul 2023 17:30

Simris Group strengthens its management team 27 jul 2023 12:00

Simris Group confirms 100% underwritten rights issue 24 jul 2023 10:51

Bulletin from the Extraordinary General Meeting 24 jul 2023 08:00

Simris Group Interim Report January-June 2023 18 jul 2023 12:15

Correction: Simris Group presents a letter from the CEO 17 jul 2023 21:35

VD för Simris Group AB, Julian Read, presenterar sina tankar kring företagets framtid 05 jul 2023 22:28

Kallelse till extra bolagsstämma i Simris Group AB (publ)05 jul 2023 22:22

SIMRIS GROUP TIDIGARELÄGGER DELÅRSRAPPORT FÖR KVARTAL 2 05 jul 2023 22:19

Simris styrelse föreslår att en bolagsstämma beslutar om en företrädesemission om högst ca 24,3 MSEK och en aktieägare föreslår en riktad emission om högst ca 26,6 MSEK 05 jul 2023 22:13

SIMRIS GROUP BEKRÄFTAR EN FÖRLÄNGNING AV FLEXIBEL FINANSIERINGSFACILITET 29 maj 2023 11:55

KOMMUNIKÉ FRÅN ÅRSSTÄMMA I SIMRIS GROUP AB 08 maj 2023 08:00

SIMRIS GROUP DELÅRSRAPPORT JANUARI-MARS 2023 05 maj 2023 18:56

SIMRIS GROUP AB BEKRÄFTAR EN FÖRLÄNGNING AV FÖRFALLODATUM FÖR DEN ANDRA DELEN FÖR FÖRVÄRVET AV CYANO BIOTECH OCH EN FÖRLÄNGNING AV FINANSIERINGSFACILITET FRÅN THE BRAND LABORATORIES 02 maj 2023 12:15

SIMRIS GROUP AB FÅR SIN STÖRSTA ORDER NÅGONSIN PÅ CIRKA 4,0 MSEK 28 apr 2023 16:08

SIMRIS GROUP AB BREDAR DISTRIBUTIONEN AV SINA OMFORMULERADE ALG OMEGA-3 PRODUKTER 27 apr 2023 12:51

KALLELSE TILL ÅRSSTÄMMA I SIMRIS GROUP AB (PUBL)21 apr 2023 19:58

SIMRIS GROUP BEKRÄFTAR EN ÖKNING AV SIN FLEXIBLA FINANSIERINGSFACILITET 17 apr 2023 21:00

SIMRIS GROUP AB MEDDELADE IDAG ATT STYRELSEN BESLUTAT ATT FLYTTA BOLAGETS ÅRSSTÄMMA FRÅN DEN 15 MAJ 2023 TILL DEN 29 MAJ 2023 17 apr 2023 20:45

SIMRIS GROUP PUBLICERAR ÅRSREDOVISNINGEN FÖR 2022 27 mar 2023 12:00

SIMRIS GROUP AB RAPPORTERAR REKORDTILLVÄXT PÅ ALGFARM 13 mar 2023 17:05

SIMRIS ALG AB BEKRÄFTAR NAMNBYTE TILL SIMRIS GROUP AB 06 mar 2023 14:00

Simris Alg ab Signs Partnership Agreement With Lonza Ltd to Promote Its Adc Payload Technology 06 mar 2023 11:30

KOMMUNIKÉ FRÅN EXTRA BOLAGSSTÄMMA I SIMRIS ALG AB (PUBL)28 feb 2023 08:00

SIMRIS ALG AB TECKNAR SAMARBETSAVTAL MED LONZA LTD FÖR ATT MARKNADSFÖRA SIN ADC PAYLOAD TEKNOLOGI 23 feb 2023 09:15

SIMRIS ALG AB BESLUTAR ATT ÄNDRA NAMN PÅ SITT DOTTERBOLAG CYANO BIOTECH GmbH TILL SIMRIS BIOLOGICS GmbH 23 feb 2023 09:15

SIMRIS ALG AB RESOLVES TO CHANGE NAME OF ITS SUBSIDIARY CYANO BIOTECH GmbH TO SIMRIS BIOLOGICS GmbH 22 feb 2023 11:30

SIMRIS ALG AB BEKRÄFTAR BEVILJANDE AV JAPANSKT PATENT SOM TÄCKER MODIFIERING AV MICROCYSTIN 22 feb 2023 11:30

SIMRIS ALG AB CONFIRMS GRANTING OF JAPANESE PATENT COVERING THE MODIFICATION OF MICROCYSTINS 15 feb 2023 16:10

Rättelse: Simris Alg bokslutskommuniké januari - december 2022 15 feb 2023 08:00

Simris Alg year-end report January-December 2022 15 feb 2023 08:00

Simris Alg bokslutskommuniké januari - december 2022 01 feb 2023 20:00

Kallelse till extra bolagsstämma i Simris Alg AB (publ)31 jan 2023 17:00

SIMRIS ALG AB FÖRESLÅR NAMNSÄNDRING TILL SIMRIS GROUP AB 31 jan 2023 17:00

SIMRIS ALG AB PROPOSES NAME CHANGE TO SIMRIS GROUP AB